Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Leukemia
×
ibrutinib
×
Clear all
Filters
3
NCT02910583
2024-12-20
Captivate
Pharmacyclics LLC.
Phase 2
Completed
323 enrolled
33 charts
NCT01578707
2019-12-18
RESONATEâ„¢
Pharmacyclics LLC.
Phase 3
Completed
391 enrolled
14 charts